You have 9 free searches left this month | for more free features.

City

Shanghai (1)

Xuzhou (1)

Condition

Adult Solid Tumor (1)

Colorectal Cancer Metastatic (1)

Lymphoma (1)

NSCLC Stage IV (1)

Solid Tumor, Adult (1)

Overall Status

Not yet recruiting (2)

Recruiting (2)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

Sponsor

Shanghai Henlius Biotech (4)

Collaborator

Intervention

hlx26 (4)

hlx10 (2)

carboplatin (1)

nab paclitaxel (1)

pemetrexed (1)

serplulimab (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

hlx26

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

Not yet recruiting

NSCLC Stage IV

HLX26
+4 more

(no location specified)

Mar 15, 2023

Adult Solid Tumor Trial (HLX26, HLX10)

Recruiting

Adult Solid Tumor

HLX26
HLX10

Xuzhou, Jiangsu, China

Xuzhou Central Hospital

Oct 17, 2022

Colorectal Cancer Metastatic Trial (HLX26, HLX10)

Not yet recruiting

Colorectal Cancer Metastatic

HLX26
HLX10

(no location specified)

Oct 14, 2022

Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)

Recruiting

Solid Tumor, Adult
Lymphoma

HLX26

Shanghai, Shanghai, China

Fudan University Shanghai Cancer Center

Jul 10, 2022